Chronic Obstructive Pulmonary Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-11-18
Clinical Trial Update: A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale [Phase 4]
Phase 4 study evaluating a tiotropium and olodaterol combination delivered by Respimat in COPD patients with varying inhalation abilities; c…
FDA approval · 2021-11-09
FDA Approved: ARFORMOTEROL TARTRATE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's original-application generic ARFORMOTEROL TARTRATE (arformoterol tartrate) for inhalation under an original ANDA.
CLINICAL_TRIALS trial_result · 2021-11-05
Clinical Trial Update: Effect of Acetazolamide on Lung Water Content by Ultrasound in Patients With Respiratory Disease at Altitude [Phase 4]
Phase 4 trial investigating whether acetazolamide affects lung water content by ultrasound in patients with chronic obstructive pulmonary di…
FDA approval · 2021-11-04
FDA Approved: YUPELRI — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for YUPELRI (revefenacin) submitted by Viatris Specialty LLC.
CLINICAL_TRIALS research · 2021-11-04
Clinical Trial Update: A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD [NA]
Clinical trial update for a technology-assisted care transition intervention targeting veterans with congestive heart failure and chronic ob…
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
CLINICAL_TRIALS trial_result · 2021-11-02
Clinical Trial Update: Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With Chronic Bronchitis and COPD [Phase 4]
A Phase 4 trial update assesses immunogenicity, safety of a third BBIBP-CorV dose, and immune persistence in elderly individuals with chroni…
CLINICAL_TRIALS trial_result · 2021-10-29
Clinical Trial Update: 2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients [Phase 3]
Phase 3 study comparing fixed combination CHF 5993 to Ultibro in COPD patients has completed.
CLINICAL_TRIALS trial_result · 2021-10-29
Clinical Trial Update: Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) Versus Combination of Fluticasone Furoate (FlF)/Vilanterol (VI) + Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial update showing non-inferiority of a fixed triple-combination inhaler (beclomethasone dipropionate + formoterol fumarate + glyc…
CLINICAL_TRIALS trial_result · 2021-10-29
Clinical Trial Update: Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 trial update for a fixed-dose inhaled combination of beclometasone, formoterol, and glycopyrrolate in chronic obstructive pulmonary …
CLINICAL_TRIALS trial_result · 2021-10-29
Clinical Trial Update: Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD [Phase 3]
Phase 3 trial comparing fixed combination therapy (beclometasone + formoterol + glycopyrrolate) to Foster in COPD; completed.
CLINICAL_TRIALS trial_result · 2021-10-29
Clinical Trial Update: Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD [Phase 3]
Phase 3 trial update evaluating efficacy and safety of a single inhaler containing beclometasone/formoterol for COPD.
CLINICAL_TRIALS trial_result · 2021-10-29
Clinical Trial Update: BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate) [Phase 3]
Phase 3 trial comparing BDP/FF to formoterol fumarate in severe COPD assessing lung function and exacerbation rate has completed.
CLINICAL_TRIALS trial_result · 2021-10-29
Clinical Trial Update: Efficacy and Safety of Glycopyrrolate Bromide of COPD Patients [Phase 2]
Phase 2 trial update on glycopyrrolate bromide in COPD evaluating efficacy and safety.
CLINICAL_TRIALS trial_result · 2021-10-29
Clinical Trial Update: Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate [Phase 2]
A Phase 2 randomized crossover trial evaluating the efficacy and safety of BDP/FF and glycopyrrolate in chronic obstructive pulmonary diseas…
CLINICAL_TRIALS trial_result · 2021-10-29
Clinical Trial Update: Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing lung deposition of the budesonide/formoterol (BDP/formoterol) combination delivered by a NEXT inhaler i…
CLINICAL_TRIALS trial_result · 2021-10-29
Clinical Trial Update: A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of "Nexthaler" Dry Powder Inhaler in COPD Patients [Phase 2]
Phase II cross-over trial evaluating pharmacodynamics of Nexthaler dry powder inhaler in COPD patients, completed.
CLINICAL_TRIALS trial_result · 2021-10-29
Clinical Trial Update: Phase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5993 Both Combined With CHF1535 BID Versus CHF1535 BID in Patients With Moderate to Severe COPD [Phase 2]
Phase II study assessing cardiac safety of two doses of CHF5993 combined with CHF1535 BID vs CHF1535 BID in moderate to severe COPD; complet…
CLINICAL_TRIALS trial_result · 2021-10-29
Clinical Trial Update: Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration [Phase 1, Phase 2]
Clinical trial update reporting safety and efficacy findings for Glyco pMDI in COPD across Phase 1 and Phase 2 completed.
CLINICAL_TRIALS trial_result · 2021-10-29
Clinical Trial Update: An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler DPI [Phase 2]
Phase 2 open-label trial evaluating inhalation profile via acoustic monitoring in COPD patients using the NEXThaler DPI; study completed.
FDA approval · 2021-10-28
FDA Approved: ALBUTEROL SULFATE — Supplemental Application (American Health Packaging)
FDA approved a supplemental application for albuterol sulfate, a generic inhalation drug, submitted by American Health Packaging.
CLINICAL_TRIALS trial_result · 2021-10-28
Clinical Trial Update: Assessing Adherence to Home Telemedicine in Individuals With Chronic Obstructive Pulmonary Disease (COPD) [NA]
A completed clinical trial evaluating adherence to home telemedicine in individuals with chronic obstructive pulmonary disease (COPD).
CLINICAL_TRIALS trial_result · 2021-10-22
Clinical Trial Update: Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD [Phase 4]
Phase 4 trial update evaluating immunogenicity and safety of an inactivated COVID-19 vaccine in elderly individuals with chronic bronchitis …
CLINICAL_TRIALS trial_result · 2021-10-22
Clinical Trial Update: Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD [Phase 4]
Phase 4 trial update evaluating immunogenicity and safety of an inactivated COVID-19 vaccine in patients aged 60 and older with chronic bron…
CLINICAL_TRIALS trial_result · 2021-10-12
Clinical Trial Update: Effect of Acetazolamide on Postural Control in Patients With Respiratory Disease at Altitude [Phase 4]
Phase 4 trial assessing the effect of acetazolamide on postural control in patients with chronic obstructive pulmonary disease at altitude.
FDA approval · 2021-09-20
FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for a generic inhalation product containing fluticasone propionate and salmeterol from Hikma Pha…